Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study

Documenti analoghi

• Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
  di: Thomas Nyström, et al.
  Pubblicazione: (2017-11-01)
• Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride
  di: J. Jendle, et al.
  Pubblicazione: (2021-12-01)
• Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
  di: Nikolai N. Scherbak, et al.
  Pubblicazione: (2023-09-01)
• Liraglutide overdose: A case report and an updated review
  di: Sharafaldeen Bin Nafisah, et al.
  Pubblicazione: (2020-01-01)
• Metformin exerts synergistic anti-proliferative effects with Liraglutide in human umbilical vein endothelial cells (HUVECs)
  di: Amir Shadboorestan, et al.
  Pubblicazione: (2022-04-01)